Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 02, 2025 09:29 ET | Source: Research and Markets

Myocardial Infarction Market Forecast Report 2025-2033 Featuring Major Players - Pfizer, BMS, AstraZeneca, Merck KGaA., Daiichi Sankyo, Novartis, Genentech, Amgen, Regeneron, Takeda

Dublin, April 02, 2025 (GLOBE NEWSWIRE) -- The "Myocardial Infarction Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to ResearchAndMarkets.com's...
October 01, 2024 07:00 ET | Source: CytoSorbents

CytoSorbents Submits DrugSorb-ATR Marketing Application to U.S. FDA to Reduce the Severity of Bleeding in Heart Bypass Surgery Patients on the Blood Thinner Ticagrelor and Provides Business Update

CytoSorbents files for FDA De Novo marketing approval of DrugSorb-ATR to reduce the severity of CABG-related bleeding due to the blood thinner ticagrelor
August 07, 2024 07:00 ET | Source: CytoSorbents

CytoSorbents to Report Second Quarter 2024 Operating and Financial Results

CytoSorbents to Report Q2 2024 Financial and Operating Results
June 20, 2024 06:28 ET | Source: Research and Markets

Myodyal Infarction Market Forecast to Reach $3.43 Billion by 2032: Global Analysis by Drug Class, Distribution Channel, Region and Company

Dublin, June 20, 2024 (GLOBE NEWSWIRE) -- The "Global Myocardial Infarction Market Report by Drug Class, Distribution Channels, Regions and Company Analysis 2024-2032" report has been added to ...
June 04, 2024 07:00 ET | Source: CytoSorbents

CytoSorbents STAR Registry Data on Patients on Ticagrelor Undergoing CABG Surgery with CytoSorb Presented at EuroPCR 2024. Named Top Five Finalist for Best Scientific Abstract

CTSO STAR Registry Data on Patients on Ticagrelor Undergoing CABG Surgery with CytoSorb Presented at EuroPCR 2024
November 16, 2023 07:28 ET | Source: Research and Markets

Blood Preparation Market Size, Share & Trends Analysis Report 2023- Global Forecast to 2030 Featuring Pfizer, Bristol-Myers Squibb, Leo Pharma, Sanofi, Xiamen Hisunny Chemical, AstraZeneca, Baxter

Dublin, Nov. 16, 2023 (GLOBE NEWSWIRE) -- The "Blood Preparation Market Size, Share & Trends Analysis Report By Product (Whole Blood, Blood Components, Blood Derivatives), Antithrombotic And...
November 02, 2023 05:03 ET | Source: Research and Markets

ESG Perspective: Sustainability Gains Importance in the Antithrombotic/Anticoagulant Drugs Market

Dublin, Nov. 02, 2023 (GLOBE NEWSWIRE) -- The "Antithrombotic/Anticoagulant Drugs: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. The global...
September 27, 2023 07:00 ET | Source: CytoSorbents

CytoSorbents Highlights Upcoming Presentations at EACTS 2023: Focus on Antithrombotic Removal including the 2nd Analysis of the International STAR Registry

CytoSorbents summarizes real-world data from STAR Registry analysis being presented next week at European Association of Cardio-Thoracic Surgery Congress
September 21, 2023 09:58 ET | Source: Research and Markets

Global Ischemic Heart Disease (IHD) Drugs Market Set to Expand, Projected Value of $7.9 Billion by 2028

Dublin, Sept. 21, 2023 (GLOBE NEWSWIRE) -- The "Ischemic Heart Disease Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ...
July 07, 2023 07:07 ET | Source: CytoSorbents

CytoSorbents Completes Enrollment of the STAR-T Pivotal Trial

PRINCETON, N.J., July 07, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using blood...

Next Page keyboard_arrow_right